Kang Eun-Chan, Kim Sung-Jin, Seo Young-Soo, Jung Sung-Soo, Seo Beom-Joo, Ryu Jeoung-Whan, Shim Joo-Cheol, Moon Jung-Joon, Jeon Dong-Wook, Park Kyoung-Duck, Jung Do-Un
Department of Psychiatry, Busan Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.
Department of Psychiatry, Sharing and Happiness Hospital, Busan, Republic of Korea.
Psychiatry Investig. 2017 Mar;14(2):141-149. doi: 10.4306/pi.2017.14.2.141. Epub 2017 Mar 6.
This study's aim was to develop and standardize a Korean version (SCoRS-K) of the Schizophrenia Cognition Rating Scale (SCoRS), which is used to evaluate the degree of cognitive dysfunction affecting the everyday functioning of people with schizophrenia.
Eighty-four schizophrenia patients with stable symptoms who were receiving outpatient treatment and rehabilitation therapy, and 29 demographically matched non-patient controls, participated in the study. Demographic data were collected, and clinical symptoms, cognitive function, and social function were evaluated to verify SCoRS-K's reliability and validity. Clinical symptoms were evaluated using the Positive and Negative Syndrome Scale and the Clinical Global Impression-Schizophrenia Scale. Cognitive function was evaluated using a short form of the Korean Wechsler Adult Intelligence Scale and the Wisconsin Card Sorting Test (WCST). Social function was evaluated using the Social and Occupational Functioning Assessment Scale, the Schizophrenia Quality of Life Scale, and the Social Functioning Scale.
Data analysis demonstrated SCoRS-K's statistically significant reliability and validity. SCoRS-K has high internal consistency (Cronbach's alpha; patient 0.941, informant 0.905, interviewer 0.964); test-retest reliability [patient 0.428 (p=0.003), informant 0.502 (p<0.001), interviewer 0.602 (p<0.001); and global rating 0.642 (p<0.001)]. The mean scores of subjects were significantly higher than those of the controls (p<0.001), demonstrating SCoRS-K's discriminant validity. Significant correlations between the total scores and global rating score of SCoRS-K and those of the scales and tests listed above (except WCST) support SCoRS-K's concurrent validity.
SCoRS-K is a useful instrument for evaluating the degree of cognitive dysfunction in Korean schizophrenia patients.
本研究旨在开发并标准化精神分裂症认知评定量表(SCoRS)的韩语版本(SCoRS-K),该量表用于评估影响精神分裂症患者日常功能的认知功能障碍程度。
84名接受门诊治疗和康复治疗且症状稳定的精神分裂症患者以及29名人口统计学匹配的非患者对照参与了本研究。收集了人口统计学数据,并对临床症状、认知功能和社会功能进行了评估,以验证SCoRS-K的信度和效度。使用阳性和阴性症状量表及临床总体印象-精神分裂症量表评估临床症状。使用韩国韦氏成人智力量表简版和威斯康星卡片分类测验(WCST)评估认知功能。使用社会和职业功能评估量表、精神分裂症生活质量量表及社会功能量表评估社会功能。
数据分析表明SCoRS-K具有统计学显著的信度和效度。SCoRS-K具有较高的内部一致性(克朗巴哈系数;患者为0.941, informant为0.905,访谈者为0.964);重测信度[患者为0.428(p = 0.003),informant为0.502(p < 0.001),访谈者为0.602(p < 0.001);总体评分0.642(p < 0.001)]。受试者的平均得分显著高于对照组(p < 0.001),表明SCoRS-K具有区分效度。SCoRS-K的总分及总体评分与上述量表和测验(WCST除外)的总分及总体评分之间存在显著相关性,支持SCoRS-K的同时效度。
SCoRS-K是评估韩国精神分裂症患者认知功能障碍程度的有用工具。